S100A9 and type 1 diabetes mellitus: Serum levels of S100A9 and calprotectin were higher in T1D patients compared to healthy controls (56), and correlated with the progression of diabetic retinoptahy in T2D patients (57), but also with insulin resistance/type 2 diabetes, metabolic risk score, and fat cell size caused by obesity (58).